Kiniksa Pharmaceuticals International (KNSA) Tax Rate Growth (1y) (2018 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Tax Rate Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - |
| 7 | Viatris | 20.23 Bn | 18.42 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 4.94 Bn | 4.47 Bn | 193.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,427.00 |
| Dec 31, 2025 | 2,233.00 |
| Sep 30, 2025 | 10,838.00 |
| Jun 30, 2025 | -24,757.00 |
| Mar 31, 2025 | 6,915.00 |
| Dec 31, 2024 | -5,509.00 |
| Sep 30, 2024 | -1,325.00 |
| Jun 30, 2024 | -103,878.00 |
| Mar 31, 2024 | 702.00 |
| Dec 31, 2023 | 19,761.00 |
| Sep 30, 2023 | 31,648.00 |
| Jun 30, 2023 | 131,211.00 |
| Mar 31, 2023 | -2,277.00 |
| Dec 31, 2022 | -21,227.00 |
| Sep 30, 2022 | -37,988.00 |
| Jun 30, 2022 | -122.00 |
| Mar 31, 2022 | -784.00 |
| Dec 31, 2021 | 88.00 |
| Sep 30, 2021 | 193.00 |
| Dec 31, 2020 | 0.00 |